Caplin Point Laboratories Ltd Share Price (CAPLIPOINT)
Check the latest share price of Caplin Point Laboratories Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Caplin Point Laboratories Ltd Stock Performance
Get live Caplin Point Laboratories Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹2,056Day's Price Range₹2,14952 Week's Low
52 Week's High
₹1,36552-Week Price Range₹2,641
| Returns % | |
| 1 Month Return | + 6.2 % |
| 3 Month Return | + 15.74 % |
| 1 Year Return | + 54.88 % |
| 3 Year Return | + 198.95 % |
| 5 Year Return | + 432.28 % |
| Market Stats | |
| Previous Close | ₹2,113.40 |
| Open | ₹2,080.00 |
| Volume | 1.13L |
| Upper Circuit | ₹2,536.00 |
| Lower Circuit | ₹1,690.80 |
Caplin Point Laboratories Ltd Fundamentals & Key Indicators
Check Caplin Point Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹16,268.78 Cr
Return on Equity (ROE)
22.43
PE Ratio (TTM)
30.33
Return on capital employed (ROCE)
28.84
Industry PE ratio
57.39
Beta (LTM)
1.5
P/B Ratio
7.2
Dividend Yield
0.38
PEG Ratio
2.92
Quarterly Earnings Growth YOY
19.84
EPS (TTM)
60.75
Sector
Pharmaceuticals
Book Value
276.38
Technical Analysis
Bullish
View Technical Analysis
How to invest in Caplin Point Laboratories Ltd?
Investing in Caplin Point Laboratories Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Caplin Point Laboratories Ltd or CAPLIPOINT on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Caplin Point Laboratories Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Caplin Point Laboratories Ltd with just a few clicks!
Caplin Point Laboratories Ltd Stock's Interest Amongst Investors
Caplin Point Laboratories Ltd Valuation
Track how Caplin Point Laboratories Ltd P/E has moved over time to understand its valuation trends.
Caplin Point Laboratories Ltd in the last 5 years
Lowest (6.76x)
March 24, 2020
Today (30.33x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (40.01x)
December 27, 2024
Today’s Price to Earnings Ratio: 30.33x
Caplin Point Laboratories Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Caplin Point Laboratories Ltd.
based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Caplin Point Laboratories Ltd. Average target price of ₹2472
Source: S&P Global Market Intelligence
Caplin Point Laboratories Ltd Share Price Target
Get share price movements and forecasts by analysts on Caplin Point Laboratories Ltd.
Caplin Point Laboratories Ltd price forecast by 3 analysts
Upside of15.50%
High
₹2516
Target
₹2472.00
Low
₹2400
Caplin Point Laboratories Ltd target price ₹2472, a slight upside of 15.5% compared to current price of ₹2140.3. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Caplin Point Laboratories Ltd revenue growth forecast
Expected growth rate Q1, FY2027:56.60%
Forecast
Actual
Including amortisation and stock based compensations
Caplin Point Laboratories Ltd EPS growth forecast
EPS estimate Q1, FY2027:66.33%
Forecast
Actual
Source: S&P Global Market Intelligence
Caplin Point Laboratories Ltd Financial Results
Get the annual and quarterly financial summary of Caplin Point Laboratories Ltd, including revenue, profit, loss and more.
Indices Featuring Caplin Point Laboratories Ltd Stock
Check stock indices that include Caplin Point Laboratories Ltd.
Caplin Point Laboratories Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Caplin Point Laboratories Ltd.
Caplin Point Laboratories Ltd Earnings Results
Caplin Point Laboratories Ltd’s net profit jumped 17.25% since last year same period to ₹142.57Cr in the Q4 2024-2025. On a quarterly growth basis, Caplin Point Laboratories Ltd has generated 2.6% jump in its net profits since last 3-months.
Read More about Earnings ResultsCaplin Point Laboratories Ltd Dividends May,2025
In the quarter ending March 2025, Caplin Point Laboratories Ltd has declared dividend of ₹3 - translating a dividend yield of 0.37%.
Read More about Dividends
Caplin Point Laboratories Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Caplin Point Laboratories Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 70.56% | 0.00 | |
| Foreign Institutions | 5.7% | 0.00 | |
| Mutual Funds | 1.74% | 0.00 | |
| Retail Investors | 21.7% | 0.00 | |
| Others | 0.29% | 0.00 |
Caplin Point Laboratories Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Caplin Point Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 16,268.78 | 86.46% | 0.50 | 461 | 1,694 | |
| BUY | 38,428.87 | 101.79% | 0.52 | 300 | 1,051 | |
| BUY | 17,430.61 | 17.42% | 0.57 | 72 | 6,702 | |
| NA | 5,383.81 | 2.8% | 0.79 | -388 | 75 | |
| BUY | 14,436.59 | 43.15% | 0.68 | 244 | 1,515 |
Caplin Point Laboratories Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Caplin Point Laboratories Ltd.
Caplin Point Acquires Mexican Pharma Firm Triwin - 04 Jun, 2025
Caplin Point Laboratories, through its subsidiary, has signed a Share Purchase Agreement to acquire Triwin Pharma S.A DE C.V, enhancing its presence in the Mexican pharmaceutical market. This strategic move aims to facilitate government tenders and establish a stock-and-sale model in Latin America.Caplin Point Signals Bullish Trend with Breakout - 20 May, 2025
Caplin Point Laboratories has broken above the ₹2,100 level, indicating the end of consolidation and a bullish trend. With strong volumes and an RSI of 71, the stock shows potential for further upside, targeting ₹2,600 while maintaining a stop loss at ₹2,000.Caplin Point Laboratories Reports Strong Q4 Earnings - 15 May, 2025
Caplin Point Laboratories reported a 17.25% increase in consolidated net profit for Q4 March 2025, reaching Rs 142.57 crore. Sales rose 10.86% to Rs 502.45 crore. For the full year, net profit increased by 17.33% to Rs 536.31 crore, with sales up 14.37% to Rs 1937.47 crore.Caplin Point Subsidiary Gains USFDA Approval - 14 May, 2025
Caplin Point Laboratories' subsidiary, Caplin Steriles, has received USFDA approval for Haloperidol Decanoate Injection, a generic treatment for schizophrenia, potentially entering a $16.4 million market.
Insights on Caplin Point Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 19 quarters, 269.88 Cr → 528.27 Cr (in ₹), with an average increase of 3.7% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 4.86% to 5.70% in Mar 2025 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Price Rise
In the last 7 days, CAPLIPOINT stock has moved up by 4.4%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 14 quarters, 74.95 Cr → 142.57 Cr (in ₹), with an average increase of 4.8% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 70.56% of holdings in Mar 2025 quarter
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 1.86% to 1.74% in Mar 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 22.47% to 21.70% in Mar 2025 quarter
About Caplin Point Laboratories Ltd
Revenue: ₹502.45Cr as on March 2025 (Q4 FY25)
Net Profit: ₹145.28Cr as on March 2025 (Q4 FY25)
Listing date: 23 Jun, 2014
Chairperson Name: C C Paarthipan
| Organisation | Caplin Point Laboratories Ltd |
| Headquarters | Chennai |
| Industry | Pharmaceuticals |
| CEO | C C Paarthipan |
| E-voting on shares | Click here to vote |
Mutual Funds that own Caplin Point Laboratories Ltd
Check out the Mutual Funds with significant holdings in Caplin Point Laboratories Ltd.
FAQs
What is Caplin Point Laboratories Ltd share price today?
Caplin Point Laboratories Ltd share price today stands at ₹2140.3, Open: ₹2080, Previous Close: ₹2113.4, High: ₹2149, Low: ₹2056, 52 Week High: ₹2641, 52 Week Low: ₹1365.
What is today's traded volume of Caplin Point Laboratories Ltd?
Today's traded volume of Caplin Point Laboratories Ltd is 1.13L. Which means that 1.13L shares of Caplin Point Laboratories Ltd were bought and sold on the stock market during today's trading session.
What is Caplin Point Laboratories Ltd's market cap today?
Today's market capitalisation of Caplin Point Laboratories Ltd is ₹16,268.78 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Caplin Point Laboratories Ltd?
Caplin Point Laboratories Ltd’s 52 week high is ₹2641 and 52 week low is ₹1365. The current share price of Caplin Point Laboratories Ltd is ₹2140.3, which is -18.96% down from its 52 week high and 56.80% up from its 52 week low.